pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Arteriosclerosis in 1 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziganshin, AU | 1 |
| Ziganshin, BA | 1 |
| Giniyatova, LR | 1 |
| Dzhordzhikiya, RK | 1 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Arteriosclerosis
| Article | Year |
|---|---|
Effect of PPADS on P2X receptor-mediated responses of human blood vessels.
Topics: Adenosine Triphosphate; Arteries; Arteriosclerosis; Blood Vessels; Femoral Vein; Gallbladder; Humans | 2004 |